Facts of Herceptin (trastuzumab)
HERCEPTIN® (trastuzumab) Intravenous Infusion
Initial U.S. Approval: 1998
Multidose vial nominally containing 440 mg Herceptin as a lyophilized,
South Delhi Pharma can facilitate patients and physicians access to commercially approved medicines, “Herceptin (trastuzumab)” to all locations in the world and in India after fulfilling the legal requirement (if applicable). Herceptin (trastuzumab) is a prescription drug and should be used under proper medical guidance and advice. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Get In Touch
Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.
The SDM is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.
M:+91-9891296838 / P:+91-11- 26532129
What Herceptin is?
Herceptin is a HER2/neu receptor antagonist indicated for:
• The treatment of HER2-overexpressing breast cancer.
• The treatment of HER2-overexpressing metastatic gastric orgastroesophageal junction adenocarcinoma.
Select patients for therapy based on an FDA-approved companion diagnostic for Herceptin.
What trastuzumab is?
Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. It is specifically used for cancer that is HER2 receptor positive. It may be used by itself or together with other chemotherapy medication. Trastuzumab is given by slow injection into a vein and injection just under the skin.
What are the Alternate Brands of Trastuzumab?
- Trasmab™ By Aureate Healthcare.
- Herceptin By Genentech
- Hertraz By Mylan
- Eleftha By Intas
- CanMab By Biocon
- Vivitra By Zydus
- Herclon By Roche
- Trasturel By Reliance
- Biceltis By Emucure